BOTHELL, WA - August 20, 2007 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand carried ultrasound, announced today it has appointed Marcus Y. Smith as Vice President, Corporate Development. In that position, Mr. Smith will be a member of Sonosite's Executive Committee and report to Kevin M. Goodwin, Sonosite President and CEO.
Mr. Smith joins Sonosite from Philips Medical Systems (PMS) where he served as Senior Director, Strategy and Business Development since 2004. In this capacity he was responsible for directing strategy and business development efforts for Patient Monitoring and Cardiac Care, a $1 billion medical technology division of PMS. While at Philips, Mr. Smith built and executed on a strong portfolio of growth opportunities focused on strengthening core business and expansion into new critical care markets.
From 2000 to 2003, Mr. Smith led JPMorgan's European logistics investment banking practice as Vice President, Investment Banking for the firm and advised major corporate and government clients on strategic alternatives in the logistics and transportation sectors. He originated and executed a broad range of transactions, including mergers, acquisitions, joint ventures, strategic alliances, equity, debt and derivatives.
"Marcus is a highly experienced executive with a proven record of achievement in multiple US and international corporate transactions," Mr. Goodwin stated. "We look forward to capitalizing on his expertise as we execute our future growth strategies."
Prior to JPMorgan, Mr. Smith held management positions with Schroder & Co., Inc.(now part of Citigroup) and Xerox Corporation. He received his BA from Duke University of North Carolina and both his MBA and MA in international affairs from Columbia University of New York.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and worldwide leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by nine subsidiaries and a global distribution network in over 90 countries. Sonosite"s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs over 550 people worldwide.
Mr. Smith joins Sonosite from Philips Medical Systems (PMS) where he served as Senior Director, Strategy and Business Development since 2004. In this capacity he was responsible for directing strategy and business development efforts for Patient Monitoring and Cardiac Care, a $1 billion medical technology division of PMS. While at Philips, Mr. Smith built and executed on a strong portfolio of growth opportunities focused on strengthening core business and expansion into new critical care markets.
From 2000 to 2003, Mr. Smith led JPMorgan's European logistics investment banking practice as Vice President, Investment Banking for the firm and advised major corporate and government clients on strategic alternatives in the logistics and transportation sectors. He originated and executed a broad range of transactions, including mergers, acquisitions, joint ventures, strategic alliances, equity, debt and derivatives.
"Marcus is a highly experienced executive with a proven record of achievement in multiple US and international corporate transactions," Mr. Goodwin stated. "We look forward to capitalizing on his expertise as we execute our future growth strategies."
Prior to JPMorgan, Mr. Smith held management positions with Schroder & Co., Inc.(now part of Citigroup) and Xerox Corporation. He received his BA from Duke University of North Carolina and both his MBA and MA in international affairs from Columbia University of New York.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and worldwide leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by nine subsidiaries and a global distribution network in over 90 countries. Sonosite"s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs over 550 people worldwide.